Specialty Physicians Discuss their Opinions of the United States Biosimilars Market

Insights into the Potential Reactions of Key Customers and Influence on Market Uptake

USD 10,000.00

* Required Fields

USD 10,000.00


Be the first to review this product

The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion was conducted to preview the thoughts and expectations of specialty physicians who would be expected to be among the first customers of biosimilars, with the objective of gaining insight into some of the major factors which could influence market uptake. The research for this service was gathered from a panel consisting of 20 pre-selected specialty physicians and was conducted via online moderated discussion boards over a three-day period. Key findings, qualitative analyses and recommendations are included.

Table of Contents

Specialty Physicians Discuss their Opinions of the United States Biosimilars Market, 2011 U.S. Biosimilars Online Discussion BoardSpecialty Physician Online Panel Discussion on BiosimilarsResearch Service

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.